Related Experiment Video
Updated: May 29, 2025

Examining BCL-2 Family Function with Large Unilamellar Vesicles
Published on: October 5, 2012
Inhibitory Potential and Binding Thermodynamics of Scyllatoxin-Based BH3 Domain Mimetics Targeting Repressor BCL2
H A D B Amarasiri1, Danushka Arachchige1, Matthew J K Vince1,2
1Department of Chemistry and Biochemistry, Ohio University, Athens, Ohio, USA.
Researchers developed novel BH3 domain mimetics, ScTx-Bax, to study B-cell lymphoma 2 (BCL2) protein interactions. These mimetics reveal that flexible BH3 domains enhance inhibition of Bcl-2, impacting apoptosis regulation.
Area of Science:
- Molecular Biology
- Biochemistry
- Structural Biology
Background:
- B-cell lymphoma 2 (BCL2) proteins regulate apoptosis by controlling mitochondrial release of factors.
- Anti-apoptotic BCL2 proteins inhibit apoptosis by binding to pro-apoptotic BCL2 protein BH3 domains.
- Understanding these interactions is crucial for developing targeted therapies.
Purpose of the Study:
- To develop and characterize BH3 domain mimetics based on scyllatoxin (ScTx) and Bax.
- To investigate the physicochemical basis of repressor/effector BCL2 protein interactions.
- To explore the role of structural flexibility in BH3 domain mimetics targeting Bcl-2.
Main Methods:
- Grafting Bax BH3 domain residues onto the scyllatoxin α-helix to create ScTx-Bax constructs.
- Utilizing competitive binding assays to determine inhibitory potential (IC50 values).
- Employing isothermal titration calorimetry (ITC) to analyze binding thermodynamics.
Main Results:
- ScTx-Bax mimetics effectively competed with Bax BH3 peptides for binding to Bcl-2 (mid-nanomolar IC50).
- Increased flexibility in ScTx-Bax BH3 domains correlated with enhanced inhibition of Bcl-2.
- Unstructured ScTx-Bax variants showed greater entropic binding efficiency but lower enthalpic efficiency compared to structured variants.
Conclusions:
- Structural properties of effector BH3 domains significantly influence BCL2 protein binding promiscuity.
- Entropic contributions favor binding to Bcl-2 for flexible BH3 domains, albeit with an enthalpic penalty.
- ScTx-based BH3 domain mimetics are valuable tools for studying BCL2 protein interactions.
More Related Videos
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
10:58Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
Published on: July 25, 2013
Related Concept Videos
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Co-activators and Co-repressors